{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:11:39Z","timestamp":1773367899644,"version":"3.50.1"},"reference-count":39,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"1","license":[{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:00:00Z","timestamp":1711843200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. Durante el desarrollo de la pandemia por SARS-CoV-2 en Antioquia se presentaron picos epidemiol\u00f3gicos relacionados con las variantes \u03b1, \u0263, \u03b2, \u019b y \u03b4, donde \u03b4 tuvo la mayor incidencia y prevalencia. Este linaje se considera una variante de preocupaci\u00f3n dadas las manifestaciones cl\u00ednicas que desencadena y sus caracter\u00edsticas epidemiol\u00f3gicas. Se han informado 253 sublinajes \u03b4 en la base de datos PANGOLIN. La identificaci\u00f3n de estos sublinajes mediante an\u00e1lisis gen\u00f3mico ha permitido rastrear su evoluci\u00f3n y propagaci\u00f3n.Objetivo. Caracterizar la diversidad gen\u00e9tica de los diferentes sublinajes \u03b4 de SARSCoV-2 en Antioquia y determinar su prevalencia.Materiales y m\u00e9todos. Se recopil\u00f3 informaci\u00f3n sociodemogr\u00e1fica de 2.675 muestras y de 1.115 genomas del repositorio GISAID entre el 12 de julio de 2021 y el 18 de enero de 2022. Se seleccionaron 501 por su alto porcentaje de cobertura (&gt;90 %) para realizar an\u00e1lisis filogen\u00e9ticos e inferencia de frecuencias al\u00e9licas de mutaciones de inter\u00e9s. Resultados. Se caracterizaron 24 sublinajes donde el m\u00e1s prevalente fue AY.25. En este sublinaje se identificaron mutaciones de inter\u00e9s como L452R, P681R y P681H, que comprend\u00edan una frecuencia cercana a 0,99. Conclusiones. Este estudio permiti\u00f3 identificar que el sublinaje AY.25 tiene una ventaja de transmisi\u00f3n en comparaci\u00f3n con los otros sublinajes \u03b4. Esto puede estar relacionado con la presencia de las mutaciones L452R y P681R que en otros estudios se han visto asociadas con una mayor transmisibilidad, evasi\u00f3n del sistema inmunitario y menor eficacia de los medicamentos contra SARS-CoV-2.<\/jats:p>","DOI":"10.7705\/biomedica.6862","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:23:00Z","timestamp":1713280980000},"page":"54-66","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiolog\u00eda gen\u00f3mica de los sublinajes \u03b4 del virus SARS-CoV-2 de la segunda ola de COVID en Antioquia en el 2021","Genomic epidemiology of SARS-CoV-2 \u03b4 sublineages of the second wave of 2021 in Antioquia, Colombia"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-1832","authenticated-orcid":false,"given":"Cristian Arbey","family":"Velarde","sequence":"first","affiliation":[{"name":"Laboratorio Departamental de Salud P\u00fablica de Antioquia, Secretar\u00eda Seccional de Salud y Protecci\u00f3n Social de Antioquia, Medell\u00edn, Colombia"},{"name":"Laboratorio Departamental de Salud P\u00fablica de Antioquia, Secretar\u00eda Seccional de Salud y Protecci\u00f3n Social de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9201-3014","authenticated-orcid":false,"given":"Uriel","family":"Hurtado","sequence":"additional","affiliation":[{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas, Medell\u00edn, Colombia"},{"name":"Corporaci\u00f3n para Investigaciones Biol\u00f3gicas, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2125-5809","authenticated-orcid":false,"given":"Andres Fernando","family":"Cardona Rios","sequence":"additional","affiliation":[{"name":"Laboratorio Gen\u00f3mico One Health, Universidad Nacional, Medell\u00edn, Colombia"},{"name":"Laboratorio Gen\u00f3mico One Health, Universidad Nacional, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7663-9167","authenticated-orcid":false,"given":"Celeny","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n de Salud Colectiva, Secretaria de Salud de Antioquia, Secretar\u00eda Seccional de Salud de Antioquia, Medell\u00edn, Colombia"},{"name":"Direcci\u00f3n de Salud Colectiva, Secretaria de Salud de Antioquia, Secretar\u00eda Seccional de Salud de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2193-5011","authenticated-orcid":false,"given":"Idabely","family":"Betancur","sequence":"additional","affiliation":[{"name":"Laboratorio Departamental de Salud P\u00fablica de Antioquia, Secretar\u00eda Seccional de Salud y Protecci\u00f3n Social de Antioquia, Medell\u00edn, Colombia"},{"name":"Laboratorio Departamental de Salud P\u00fablica de Antioquia, Secretar\u00eda Seccional de Salud y Protecci\u00f3n Social de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2024,3,31]]},"reference":[{"key":"132062","unstructured":"Instituto Nacional de Salud. Casos COVID 19. Colombia, 2020 - 2022. Fecha de consulta: 25 de abril de 2022. Disponible en: https:\/\/app.powerbi.com\/viewr=eyJrIjoiMjBjZWNlOGUtNzc1Yi00NjVkLTkyMjktOTJmMGU3YTU2Nzk4IiwidCI6ImE2MmQ2YzdiLTlmNTktNDQ2OS05MzU5LTM1MzcxNDc1OTRiYiIsImMiOjR9&pageName=ReportSection0c50ea3406afe4407370"},{"key":"132063","doi-asserted-by":"crossref","unstructured":"Laiton-Donato K, Villabona-Arenas CJ, Usme-Ciro JA, Franco-Mu\u00f1oz C, \u00c1lvarez-D\u00edaz DA, Villabona-Arenas LS, et al. Genomic epidemiology of severe acute respiratory syndrome coronavirus 2, Colombia. Emerg Infect Dis. 2020;26: 2854-62. https:\/\/doi.org\/10.3201\/eid2612.202969","DOI":"10.3201\/eid2612.2969"},{"key":"132064","doi-asserted-by":"crossref","unstructured":"Vel\u00e1squez Cuadros CH, Almanza Payares RE, Silva L\u00f3pez YJ. Clinical, epidemiological and virological findings of the first COVID-19 outbreak in Medell\u00edn, Antioquia, Colombia. Rev Fac Nac Salud P\u00fablica. 2022;40:e344675. https:\/\/doi.org\/10.17533\/udea.rfnsp.e344675","DOI":"10.17533\/udea.rfnsp.e344675"},{"key":"132065","doi-asserted-by":"crossref","unstructured":"Betancur I, Velarde CA, Ortiz C. Situaci\u00f3n epidemiol\u00f3gica de las variantes de SARSCoV-2 detectadas en Antioquia desde diciembre 2020 a enero 2022. Fecha de consulta: 25 de abril de 2022. Disponible en: https:\/\/www.dssa.gov.co\/images\/2022\/documentos\/investigaciones\/Epidemiologia_de_SARS_CoV-2_en_Antioquia_2020-2022.pdf","DOI":"10.33610\/01229907.2022v4n1a4"},{"key":"132066","unstructured":"Laboratoire National de R\u00e9f\u00e9rence pour les Infections Respiratoires Aigu\u00ebs. Delta variant B.1.617.2 lineage and AY sublineages. 2021. Fecha de consulta: 19 de octubre de 2022. Disponible en: https:\/\/lns.lu\/wp-content\/uploads\/2021\/09\/lns-scientific-briefing-deltasublineages_final_en_v20210913.pdf"},{"key":"132067","unstructured":"World Health Organization. COVID-19 weekly epidemiological update, 31 August 2021.2021. Fecha de consulta: 19 de octubre de 2022. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/344799?locale-attribute=es&"},{"key":"132068","doi-asserted-by":"crossref","unstructured":"Taboada B, Z\u00e1rate S, Garc\u00eda-L\u00f3pez R, Mu\u00f1oz-Medina JE, S\u00e1nchez-Flores A, Herrera-Estrella A, et al. Dominance of three sublineages of the SARSCoV-2 delta variant in Mexico. Viruses. 2022;14:1165. https:\/\/doi.org\/10.3390\/v14061165","DOI":"10.3390\/v14061165"},{"key":"132069","doi-asserted-by":"crossref","unstructured":"Elliott P, Haw D, Wang H, Eales O, Walters CE, Ainslie KEC, et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the delta variant. Science. 2021;374:eabl9551. https:\/\/doi.org\/10.1126\/science.abl9551","DOI":"10.1126\/science.abl9551"},{"key":"132070","doi-asserted-by":"crossref","unstructured":"Cherian S, Potdar V, Jadhav S, Yadav P, Gupta N, Das M, et al. SARSCoV2 spike mutations, l452r, t478k, e484q and p681r, in the second wave of COVID-19 in Maharashtra, India. Microorganisms. 2021;9:1542. https:\/\/doi.org\/10.3390\/microorganisms9071542","DOI":"10.3390\/microorganisms9071542"},{"key":"132071","unstructured":"Instituto Nacional de Salud. Caracterizaci\u00f3n gen\u00f3mica de SARS-CoV-2 por muestreo probabil\u00edstico en Colombia - Tercer muestreo periodo octubre de 2021. Bogot\u00e1: Instituto Nacional de Salud; 2021. Disponible en: http:\/\/www.ins.gov.co\/BibliotecaDigital\/Tercer_muestreo-Estrategia-caracterizacion-genomica-muestreo-probabilistico-SARS-CoV-2.pdf"},{"key":"132072","doi-asserted-by":"crossref","unstructured":"Betancur I, Velarde CA, Ortiz C. Situaci\u00f3n epidemiol\u00f3gica de las variantes de Sars-CoV-2 detectadas en Antioquia desde diciembre 2020 a enero 2022. Bolet\u00edn Epidemiol\u00f3gico de Antioquia. 2021. Disponible en: https:\/\/www.dssa.gov.co\/images\/2022\/documentos\/investigaciones\/Epidemiologia_de_SARS_CoV-2_en_Antioquia_2020-2022.pdf","DOI":"10.33610\/01229907.2022v4n1a4"},{"key":"132073","doi-asserted-by":"crossref","unstructured":"Rambaut A, Holmes EC, O\u2019Toole \u00c1, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403. https:\/\/doi.org\/10.1038\/s41564-020-0770-5","DOI":"10.1038\/s41564-020-0770-5"},{"key":"132074","doi-asserted-by":"crossref","unstructured":"Garcia-Beltran WF, St. Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARSCoV-2 \u00f3micron variant. Cell. 2022;185:457. https:\/\/doi.org\/10.1101\/2021.12.14.21267755","DOI":"10.1016\/j.cell.2021.12.033"},{"key":"132075","doi-asserted-by":"crossref","unstructured":"Modes ME, Directo MP, Melgar M, Johnson LR, Yang H, Chaudhary P, et al. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARSCoV-2 infection during periods of B.1.617.2 (delta) and B.1.1.529 (\u00f3micron) variant predominance \u2014 One Hospital, California, July 15-September 23, 2021, and December 21, 2021\u2013January 27, 2022. MMWR Recomm Reports. 2022;71:217-23. https:\/\/doi.org\/10.15585\/mmwr.mm7106e2","DOI":"10.15585\/mmwr.mm7106e2"},{"key":"132076","doi-asserted-by":"crossref","unstructured":"Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data \u2013 From vision to reality. Euro Surveill. 2017;22:30494. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.13.30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494"},{"key":"132077","unstructured":"Artic Networ. Artic Network. 2019. Fecha de consulta: 11 de agosto de 2022. Disponible en: https:\/\/artic.network\/ncov-2019\/ncov2019-it-setup.html"},{"key":"132078","doi-asserted-by":"crossref","unstructured":"Quick J. nCoV-2019 sequencing protocol V.1. Protocolo.io. 2021. Fecha de consulta: 19 de octubre de 2022. Disponible en: https:\/\/www.protocols.io\/view\/ncov-2019-sequencingprotocol-bp2l6n26rgqe\/v1?version_warning=no","DOI":"10.17504\/protocols.io.bbmuik6w"},{"key":"132079","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez S, Prado-Vivar B, Guadalupe JJ, Guti\u00e9rrez-Granja B, Jibaja M, Tobar M, et al. Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador. medRxiv. 2020:2020.06.11.20128330. https:\/\/doi.org\/10.1101\/2020.06.11.20128330","DOI":"10.1101\/2020.06.11.20128330"},{"key":"132080","unstructured":"IBM. SPSS Statistics. Fecha de consulta: 19 de octubre de 2022. Disponible en: https:\/\/www.ibm.com\/mysupport\/s\/topic\/0TO500000001yjtGAA\/spss-statistics?language=en_US.2022 [citado 19 de octubre de 2022]. Disponible en: https:\/\/www.ibm.com\/mysupport\/s\/topic\/0TO500000001yjtGAA\/spss-statistics?language=en_US"},{"key":"132081","doi-asserted-by":"crossref","unstructured":"Edgar RC. MUSCLE: A multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004:5:113. https:\/\/doi.org\/10.1186\/1471-2105-5-113","DOI":"10.1186\/1471-2105-5-113"},{"key":"132082","doi-asserted-by":"crossref","unstructured":"Capella-Guti\u00e9rrez S, Silla-Mart\u00ednez JM, Gabald\u00f3n T. trimAl: A tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics. 2009;25:1972-3. https:\/\/doi.org\/10.1093\/bioinformatics\/btp348","DOI":"10.1093\/bioinformatics\/btp348"},{"key":"132083","doi-asserted-by":"crossref","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: Molecular evolutionary genetics analysis, version 11. Mol Biol Evol. 2021;38 :3022-7. https:\/\/doi.org\/10.1093\/molbev\/msab120","DOI":"10.1093\/molbev\/msab120"},{"key":"132084","doi-asserted-by":"crossref","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530-4. https:\/\/doi.org\/10.1093\/molbev\/msaa015","DOI":"10.1093\/molbev\/msaa015"},{"key":"132085","doi-asserted-by":"crossref","unstructured":"Sielemann K, Pucker B, Schmidt N, Vieh\u00f6ver P, Weisshaar B, Heitkam T, et al. Complete pan-plastome sequences enable high resolution phylogenetic classification of sugar beet and closely related crop wild relatives. BMC Genomics. 2022;23:113. https:\/\/doi.org\/10.1186\/s12864-022-08336-8","DOI":"10.1186\/s12864-022-08336-8"},{"key":"132086","doi-asserted-by":"crossref","unstructured":"Cock PJA, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. Biopython: Freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422-3. https:\/\/doi.org\/10.1093\/bioinformatics\/btp163","DOI":"10.1093\/bioinformatics\/btp163"},{"key":"132087","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Silva C, Rivero R, Douglas J, Bouckaert R, Villabona-Arenas CJ, Atkins KE, et al. Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia. Commun Med (Lond). 2023;3:97. https:\/\/doi.org\/10.1038\/s43856-023-00328-3","DOI":"10.1101\/2022.06.20.22275744"},{"key":"132088","unstructured":"Murall CL, Poujol R, Petkau A, Sobkowiak B, Zetner A, Kraemer SA, et al. Monitoring the evolution and spread of delta sublineages AY.25 and AY.27 in Canada. 2021. Fecha de consulta: 19 de octubre de 2022. Disponible en: https:\/\/virological.org\/t\/monitoring-theevolution-and-spread-of-delta-sublineages-ay-25-and-ay-27-in-canada\/767"},{"key":"132089","doi-asserted-by":"crossref","unstructured":"Brown CM, Vostok J, Johnson H, Burns M, Gharpure R, Sami S, et al. Outbreak of SARSCoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings \u2014 Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1059-62. https:\/\/doi.org\/10.15585\/mmwr.mm7031e2","DOI":"10.15585\/mmwr.mm7031e2"},{"key":"132090","doi-asserted-by":"crossref","unstructured":"Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. NextStrain: Realtime tracking of pathogen evolution. Bioinformatics. 2018;34:4121-3. https:\/\/doi.org\/10.1093\/bioinformatics\/bty407","DOI":"10.1093\/bioinformatics\/bty407"},{"key":"132091","doi-asserted-by":"crossref","unstructured":"Rabi FA, Al Zoubi MS, Al-Nasser AD, Kasasbeh GA, Salameh DM. SARSCoV-2 and coronavirus disease 2019: What we know so far. Pathogens. 2020;9:231. https:\/\/doi.org\/10.3390\/pathogens9030231","DOI":"10.3390\/pathogens9030231"},{"key":"132092","doi-asserted-by":"crossref","unstructured":"Motozono C, Toyoda M, Zahradnik J, Saito A, Nasser H, Tan TS, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-36. https:\/\/doi.org\/10.1016\/j.chom.2021.06.006","DOI":"10.1016\/j.chom.2021.06.006"},{"key":"132093","doi-asserted-by":"crossref","unstructured":"Selzer T, Albeck S, Schreiber G. Rational design of faster associating and tighter binding protein complexes. Nat Struct Biol. 2000;7:537-41. https:\/\/doi.org\/10.1038\/76744","DOI":"10.1038\/76744"},{"key":"132094","doi-asserted-by":"crossref","unstructured":"Deng X, Garcia-Knight MA, Khalid MM, Servellita V, Wang C, Morris MK, et al. Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. medRxiv. 2021:2021.03.07.21252647. https:\/\/doi.org\/10.1101\/2021.03.07.21252647","DOI":"10.1101\/2021.03.07.21252647"},{"key":"132095","doi-asserted-by":"crossref","unstructured":"Liu Y, Liu J, Johnson BA, Xia H, Ku Z, Schindewolf C, et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over alfa variant. Cell Rep. 2022;39:110829. https:\/\/doi.org\/10.1016\/j.celrep.2022.110829","DOI":"10.1016\/j.celrep.2022.110829"},{"key":"132096","doi-asserted-by":"crossref","unstructured":"Pastrian-Soto G, Pastrian-Soto G. Presencia y expresi\u00f3n del receptor ACE2 (Target de SARS-CoV-2) en tejidos humanos y cavidad oral. Posibles rutas de infecci\u00f3n en \u00f3rganos orales. Int J Odontostomatol. 2020;14:501-7. https:\/\/doi.org\/10.4067\/S0718-381X2020000400501","DOI":"10.4067\/S0718-381X2020000400501"},{"key":"132097","doi-asserted-by":"crossref","unstructured":"Lubinski B, Fernandes MH V., Frazier L, Tang T, Daniel S, Diel DG, et al. Functional evaluation of the P681H mutation on the proteolytic activation the SARS-CoV-2 variant B.1.1.7 (Alfa) spike. iScience. 2022;25:103589. https:\/\/doi.org\/10.1016\/j.isci.2021.103589","DOI":"10.1016\/j.isci.2021.103589"},{"key":"132098","doi-asserted-by":"crossref","unstructured":"Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, et al. SARSCoV2 neutralizing antibody LY-CoV555 in outpatients with COVID19. N Engl J Med. 2021;384:229-37. https:\/\/doi.org\/10.1056\/NEJMoa2029849","DOI":"10.1056\/NEJMoa2029849"},{"key":"132099","doi-asserted-by":"crossref","unstructured":"Liu H, Wei P, Kappler JW, Marrack P, Zhang G. SARS-CoV-2 Variants of concern and variants of interest receptor binding domain mutations and virus infectivity. Front Immunol. 2022;13:825256. https:\/\/doi.org\/10.3389\/fimmu.2022.825256","DOI":"10.3389\/fimmu.2022.825256"},{"key":"132100","doi-asserted-by":"crossref","unstructured":"Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. 2021;29:44. https:\/\/doi.org\/10.1016\/j.chom.2020.11.007","DOI":"10.1016\/j.chom.2020.11.007"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6862\/5448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6862\/5564","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6862\/5448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:18:37Z","timestamp":1773325117000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,31]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6862","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,31]]},"assertion":[{"value":"2024-03-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}